The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery
Open accessAbstract
Abstract Objective To evaluate whether a screening strategy in pregnancy lowers the rate of preterm delivery in a general population of pregnant women. Design Multicentre, prospective, randomised controlled trial. Setting Non-hospital based antenatal clinics. Participants 4429 pregnant women presenting for their routine prenatal visits early in the second trimester were screened by Gram stain for asymptomatic vaginal infection. In the intervention group, the women9s obstetricians received the test results and women received standard treatment and follow up for any detected infection. In the control group, the results of the vaginal smears were not revealed to the caregivers. Main outcome measures The primary outcome variable was preterm delivery at less than 37 weeks. Secondary outcome variables were preterm delivery at less than 37 weeks combined with different birth weight categories equal to or below 2500 g and the rate of late miscarriage. Results Outcome data were available for 2058 women in the intervention group and 2097 women in the control group. In the intervention group, the number of preterm births was significantly lower than in the control group (3.0% v 5.3%, 95% confidence interval 1.2 to 3.6; P = 0.0001). Preterm births were also significantly reduced in lower weight categories at less than 37 weeks and ≤ 2500 g. Eight late miscarriages occurred in the intervention group and 15 in the control group. Conclusion Integrating a simple infection screening programme into routine antenatal care leads to a significant reduction in preterm births and reduces the rate of late miscarriage in a general population of pregnant women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nugent, R. P., Krohn, M. A., & Hillier, S. L. (1991) · Journal of Clinical Microbiology · doi:10.1128/jcm.29.2.297-301.1991 · Cited by 3,331
A Case–Control Study of Chorioamnionic Infection and Histologic Chorioamnionitis in Prematurity
Hillier, S. L., Martius, J., Krohn, M., Kiviat, N., Holmes, K. K., & Eschenbach, D. A. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810133191503 · Cited by 992
A review of premature birth and subclinical infection
Gibbs, R. S., Romero, R., Hillier, S. L., Eschenbach, D. A., & Sweet, R. L. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(92)91628-n · Cited by 891
Metronidazole to Prevent Preterm Delivery in Pregnant Women with Asymptomatic Bacterial Vaginosis
Carey, J. C., Klebanoff, M. A., Hauth, J. C., Hillier, S. L., Thom, E. A., Ernest, J. M., Heine, R. P., Nugent, R. P., Fischer, M. L., Leveno, K. J., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002243420802 · Cited by 673
Hay, P. E., Lamont, R. F., Taylor-Robinson, D., Morgan, D. J., Ison, C., & Pearson, J. (1994) · BMJ · doi:10.1136/bmj.308.6924.295 · Cited by 651
Antibiotics for treating bacterial vaginosis in pregnancy
Brocklehurst, P., Gordon, A., Heatley, E., & Milan, S. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000262.pub4 · Cited by 616
Gravett, M. G. (1986) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1986.03380140069024 · Cited by 544
Mercer, B. M., Goldenberg, R. L., Moawad, A. H., Meis, P. J., Iams, J. D., Das, A. F., Caritis, S. N., Miodovnik, M., Menard, M. K., Thurnau, G. R., et al. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70111-0 · Cited by 520
The preterm prediction study: significance of vaginal infections
Meis, P. J., Goldenberg, R. L., Mercer, B., Moawad, A., Das, A., McNellis, D., Johnson, F., Iams, J. D., Thom, E., & Andrews, W. W. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)91360-2 · Cited by 410
The management of preterm labor*1
GOLDENBERG, R. (2002) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(02)02212-3 · Cited by 405
Cited by
An Introduction to Research Methods
(2019) · Data Collection Research Methods in Applied Linguistics · doi:10.5040/9781350025875.ch-001 · Cited by 2,362
AN INTRODUCTION TO RESEARCH METHODS
(2000) · Morphometrics for the Life Sciences · doi:10.1142/9789812813060_0002 · Cited by 716
Antibiotics for treating bacterial vaginosis in pregnancy
Brocklehurst, P., Gordon, A., Heatley, E., & Milan, S. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000262.pub4 · Cited by 616
Iams, J. D., Romero, R., Culhane, J. F., & Goldenberg, R. L. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60108-7 · Cited by 500
Leitich, H., & Kiss, H. (2007) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2006.12.005 · Cited by 342
Self-citationTrichomonas vaginalis as a Cause of Perinatal Morbidity: A Systematic Review and Meta-Analysis
Silver, B. J., Guy, R. J., Kaldor, J. M., Jamil, M. S., & Rumbold, A. R. (2014) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000134 · Cited by 252
Guideline: Vulvovaginal Candidosis (AWMF 015/072, Level S2k)
Farr, A., Effendy, I., Frey Tirri, B., Hof, H., Mayser, P., Petricevic, L., Ruhnke, M., Schaller, M., Schaefer, A. P. A., Sustr, V., et al. (2021) · Mycoses · doi:10.1111/myc.13248 · Cited by 184
Guideline: Vulvovaginal Candidosis (AWMF 015/072), S2k (Excluding Chronic Mucocutaneous Candidosis)
Mendling, W. (2015) · Mycoses · doi:10.1111/myc.12292 · Cited by 117
US Preventive Services Task Force, Owens, D. K., Davidson, K. W., Krist, A. H., Barry, M. J., Cabana, M., Caughey, A. B., Donahue, K., Doubeni, C. A., Epling, J. W., et al. (2020) · JAMA · doi:10.1001/jama.2020.2684 · Cited by 73
Metadata
- Authors
- Kiss, H., Petricevic, L., & Husslein, P.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2004-08-04
- Volume
- 329
- Issue
- 7462
- Pages
- 371
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2078797436
- Cited by
- 330
- References
- 27
- FWCI
- 13.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.